Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
基本信息
- 批准号:10681989
- 负责人:
- 金额:$ 71.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-01 至 2028-03-31
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAddressAffectAffinityAntigen-Presenting CellsAntigensApplications GrantsAutomobile DrivingBiological AssayBiophysicsCD8-Positive T-LymphocytesCell SurvivalCell membraneCell physiologyCell surfaceCellsCellular biologyDataDevelopmentEngineeringEquationGoalsIL17 geneIL2RA geneImmune responseIn SituInfectionInfectious AgentInfluenzaInterferon Type IIInterleukin-10Interleukin-2JointsKnowledgeLigandsListeriaLymphocytic choriomeningitis virusMHC InteractionMHC antigenMeasuresMediatingMembraneMemoryMethodsMindModelingMusOX40OutcomePeptide/MHC ComplexPeptidesPeripheralPhenotypePlasmodiumPlayProteinsProxyPublishingReceptor SignalingRegulatory T-LymphocyteReporterRoleSignal TransductionSurfaceT cell responseT-Cell ReceptorT-LymphocyteTCR ActivationTechnologyThymocyte DevelopmentTissuesTranslatingWorkbiophysical propertiescomplementarity-determining region 3driving forcefunctional outcomesmicrobial genomenovelprogrammed cell death protein 1responsesegregationtwo-dimensional
项目摘要
Abstract
Recognition of antigen is the first critical step required in triggering T cell survival, expansion, development of
effector functions, and transition to memory. In a joint project between the Evavold and Williams labs, we will
determine how T cell receptor (TCR) and peptide:MHC (pMHC) affinity, bond lifetimes, and force magnitude
define T cell phenotype. The proposed work is therefore impactful as it begins to delineate the role each of
these parameters play in the rich T cell biology associated with TCR signal strength. To date, the concept of
TCR strength of signal has generally been described with three-dimensional SPR affinity in mind and
measured via representative surface markers, pMHC tetramers, and functional readouts. In contrast to these
methods, our studies depend on the analysis of TCR and pMHC interactions at the surface of the cell
membrane using novel assays that define the in-situ two-dimensional contact that occurs between T cells and
APCs during antigen recognition. The preliminary work has discovered that bond lifetime and level of force as
opposed to affinity provides the major driving force for phenotypic fate. The three specific aims will redefine the
concept of TCR strength of signal, dissect affinity from bond lifetime, and determine outcomes of low affinity
TCRs during infection. Currently, the TCR affinity and bond lifetime for pMHC are unknown for many T cell
responses, limiting our knowledge on how T cell mediated responses are triggered and how affinity and bond
lifetime are translated into TCR strength of signal and effector phenotypes. Therefore, our work will prove
insightful by addressing the discrepancy between affinity based predictions and actual T cell functional
outcomes.
抽象的
识别抗原是触发T细胞存活,膨胀,发展的第一个关键步骤
效应器功能,并过渡到内存。在《逃亡者》和威廉姆斯实验室之间的联合项目中,我们将
确定T细胞受体(TCR)和肽:MHC(PMHC)亲和力,键寿命和力幅度如何
定义T细胞表型。因此,拟议的工作具有影响力,因为它开始描述每个角色
这些参数在与TCR信号强度相关的丰富T细胞生物学中起作用。迄今为止,
通常用三维SPR亲和力描述了信号的TCR强度
通过代表性的表面标记,PMHC四聚体和功能读数测量。与这些相反
方法,我们的研究取决于细胞表面TCR和PMHC相互作用的分析
膜使用定义T细胞之间发生的原位二维接触的新颖测定法
抗原识别期间的APC。初步工作发现债券的寿命和力量是
与亲和力相反,为表型命运提供了主要的驱动力。这三个具体目标将重新定义
信号的TCR强度的概念,从键寿命中解剖亲和力,并确定低亲和力的结果
感染期间的TCR。目前,PMHC的TCR亲和力和键寿命在许多T细胞中都是未知的
响应,限制了我们关于如何触发T细胞介导的响应以及如何亲和力和联系的知识
寿命被转化为信号和效应子表型的TCR强度。因此,我们的工作将证明
通过解决基于亲和力的预测与实际T细胞功能之间的差异来有见地
结果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brian D Evavold其他文献
Brian D Evavold的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Brian D Evavold', 18)}}的其他基金
Defining how TCR strength of signal modulates Treg function
定义 TCR 信号强度如何调节 Treg 功能
- 批准号:
10707431 - 财政年份:2022
- 资助金额:
$ 71.79万 - 项目类别:
Defining how TCR strength of signal modulates Treg function
定义 TCR 信号强度如何调节 Treg 功能
- 批准号:
10608466 - 财政年份:2022
- 资助金额:
$ 71.79万 - 项目类别:
Biomedical Research Inclusion & Diversity to Grow Excellence in Science - Undergraduate Program in Pathology for HBCUs (BRIDGE-UP HBCU)
生物医学研究包容性
- 批准号:
10487779 - 财政年份:2022
- 资助金额:
$ 71.79万 - 项目类别:
Pathogenic low affinity CD8 T cells in malaria
疟疾中的致病性低亲和力 CD8 T 细胞
- 批准号:
10490915 - 财政年份:2021
- 资助金额:
$ 71.79万 - 项目类别:
Pathogenic low affinity CD8 T cells in malaria
疟疾中的致病性低亲和力 CD8 T 细胞
- 批准号:
10392126 - 财政年份:2021
- 资助金额:
$ 71.79万 - 项目类别:
Pathogenic low affinity CD8 T cells in malaria
疟疾中的致病性低亲和力 CD8 T 细胞
- 批准号:
10676265 - 财政年份:2021
- 资助金额:
$ 71.79万 - 项目类别:
CD8 T cell antigen recognition during chronic infection
慢性感染期间CD8 T细胞抗原识别
- 批准号:
10356105 - 财政年份:2020
- 资助金额:
$ 71.79万 - 项目类别:
CD8 T cell antigen recognition during chronic infection
慢性感染期间CD8 T细胞抗原识别
- 批准号:
10582733 - 财政年份:2020
- 资助金额:
$ 71.79万 - 项目类别:
Cross-disciplinary Training in Immunology, Inflammation and Infectious Disease
免疫学、炎症和传染病的跨学科培训
- 批准号:
10413164 - 财政年份:2018
- 资助金额:
$ 71.79万 - 项目类别:
Cross-disciplinary Training in Immunology, Inflammation and Infectious Disease
免疫学、炎症和传染病的跨学科培训
- 批准号:
9923527 - 财政年份:2018
- 资助金额:
$ 71.79万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
A HUMAN IPSC-BASED ORGANOID PLATFORM FOR STUDYING MATERNAL HYPERGLYCEMIA-INDUCED CONGENITAL HEART DEFECTS
基于人体 IPSC 的类器官平台,用于研究母亲高血糖引起的先天性心脏缺陷
- 批准号:
10752276 - 财政年份:2024
- 资助金额:
$ 71.79万 - 项目类别:
Fluency from Flesh to Filament: Collation, Representation, and Analysis of Multi-Scale Neuroimaging data to Characterize and Diagnose Alzheimer's Disease
从肉体到细丝的流畅性:多尺度神经影像数据的整理、表示和分析,以表征和诊断阿尔茨海默病
- 批准号:
10462257 - 财政年份:2023
- 资助金额:
$ 71.79万 - 项目类别:
Endothelial Cell Reprogramming in Familial Intracranial Aneurysm
家族性颅内动脉瘤的内皮细胞重编程
- 批准号:
10595404 - 财政年份:2023
- 资助金额:
$ 71.79万 - 项目类别:
An Engineered Hydrogel Platform to Improve Neural Organoid Reproducibility for a Multi-Organoid Disease Model of 22q11.2 Deletion Syndrome
一种工程水凝胶平台,可提高 22q11.2 缺失综合征多器官疾病模型的神经类器官再现性
- 批准号:
10679749 - 财政年份:2023
- 资助金额:
$ 71.79万 - 项目类别: